Who is sponsoring NCT02447614?

NCT02447614 is sponsored by Beijing Children's Hospital.

What condition does NCT02447614 study?

NCT02447614 studies Obstructive Sleep Apnea Syndrome.

What drugs are being tested in NCT02447614?

Interventions: Adenotonsillectomy, Conservative treatment, no treatment.

What is the status of NCT02447614?

NCT02447614 is currently COMPLETED.

Last reviewed 2022-07-19 · How we verify

Follow-up Studies of PS and OSAHS in Chinese Children

NCT02447614 COMPLETED

The study is designed to investigate the natural course of Primary snoring in 1-2 years or more and the different effect of drug and surgical treatment applied in children with obstructive sleep apnea (OSAS) by comparing the polysomnography(PSG) and sleep questionaires in 6 months after treatment.

Details

Lead sponsor	Beijing Children's Hospital
Status	COMPLETED
Enrolment	500
Start date	2014-11
Completion	2022-07-01

Conditions

Obstructive Sleep Apnea Syndrome

Interventions

Adenotonsillectomy
Conservative treatment
no treatment

Primary outcomes

The changes of PSG parameters of children with PS or OSAS — 6 months
In our study, there are 55 children of mild to moderate SDB with conservative treatment, among which 23 children are chosen in PS group and 32 children are chosen in OSAS group. For PSG, according to the value of OAHI to determine the improvement of the child, the value of OAHI is decreased by ≥ 25% for improvement. In the PS group, there were 2 cases with improvement, and the corresponding remission rate was 8.7%. In the OSAS group, there are 22 cases with improvement, and the corresponding remission rate was 68.8%. There was a significant difference between the remission rate of PS group and that of OSAS group (P\<0.001).

Countries

China